Category: Immuno-oncology therapies
The Evolving Landscape of Oncology Drug Development Increasing incidence rates and the rise of novel therapies Oncology is the largest therapeutic area Read Now
Key Insights from SITC 2024 Overcoming Cancer Resistance to Immunotherapy The Society for Immunotherapy of Cancer (SITC) is the premier Read Now
Highlights from HubXchange Immunotherapies Maryland 2024 Optimizing dose and leveraging biomarkers for enhanced patient safety in immunotherapy trials HubXchange Immunotherapies brought Read Now
Helping to Bring Antibody Drug Conjugates (ADCs) to Patients Catalyst Oncology is a specialty oncology contract research organization (CRO) devoting time, energy, and capital Read Now
Helping to Bring Cancer Therapies to Patients Niche CRO with a difference Catalyst Oncology is a niche oncology CRO devoting time, energy, Read Now
Helping to Bring Immunotherapies to Cancer Patients in Need Catalyst Oncology is a specialty oncology clinical research organization (CRO) devoting time, energy, and capital Read Now